2018

Gilis-Januszewska A, Lindstrom J, Barengo NC, Tuomilehto J, Schwarz PE, Wojtowicz E, Piwonska-Solska B, Szybinski Z, Windak A, Hubalewska-Dydejczyk A. Predictors of completing a primary health care diabetes prevention intervention programme in people at high risk of type 2 diabetes: Experiences of the DE-PLAN project. Medicine (Baltimore). 2018;97(5):e9790

Dahlqvist S, Ahlen E, Filipsson K, Gustafsson T, Hirsch IB, Tuomilehto J, Imberg H, Ahren B, Attvall S, Lind M. Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3). BMJ Open Diabetes Res Care. 2018;6(1):e000464.

Bertoli-Avella AM, Garcia-Aznar JM, Al-Mulla F, Rolfs Abauer P. Biallelic inactivating variants in the GTPBP2 gene cause a neurodevelopmental disorder with severe intellectual disability. Online First: Eur J Hum Genet. 2018; doi:10.1038/s41431-018-0097-3

Al-Serri A, Al-Bustan S.A, Kamkar M, Thomas D, Al-Smaidi O, Al-Temaimi R, Mojiminiyi O.A, Abdella N. Association of FTO rs9939609 with Obesity in The Kuwaiti Population: A Public Health Concern?. Med Princ Pract. 2018; doi: 10.1159/000486767.

Al Madhoun A, Alkandari S, Ali H, Carrio N, Atari M, Bitar MS, Al-Mulla F. Chemically Defined Conditions Mediate an Efficient Induction of Mesodermal Lineage from Human Umbilical Cord- and Bone Marrow- Mesenchymal Stem Cells and Dental Pulp Pluripotent-Like Stem Cells. Cell Reprogram. 2018;20(1):9-16

Turcot V, Lu Y, Highland HM, Schurmann C, Justice AE, Fine RS, Bradfield JP, Esko T, Giri A, Graff M…Tuomilehto J. et al. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet. 2018;50(1):26-41.

Solomon A, Turunen H, Ngandu T, Peltonen M, Levalahti E, Helisalmi S, Antikainen R, Backman L, Hanninen T, Jula A,... Tuomilehto J, et al. Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial. online first JAMA Neurol. 2018; doi: 10.1001/jamaneurol.2017.4365

Sindhu S, Akhter N, Kochumon S, Thomas R, Wilson A, Shenouda S, Tuomilehto J, Ahmad R. Increased Expression of the Innate Immune Receptor TLR10 in Obesity and Type-2 Diabetes: Association with ROS-Mediated Oxidative Stress. Cell Physiol Biochem. 2018;45:572-590.

Shahim B, Gyberg V, De Bacquer D, Kotseva K, De Backer G, Schnell O, Tuomilehto J, Wood D, Ryden L. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology. Cardiovasc Diabetol. 2018;17(1):21.

Mezzavilla M, Tomei S, Alkayal F, Melhem M, Ali MM, Al-Arouj M, Bennakhi A, Alsmadi O, Elkum N. Investigation of genetic variation and lifestyle determinants in vitamin D levels in Arab individuals. J Transl Med. 2018;16(1):20.

Madhu D, Hammad M, Kavalakatt S, Khadir A, Tiss A. GLP-1 analogue, Exendin-4, modulates MAPKs activity but not the heat shock response in human HepG2 cells. Proteomics Clin. Appl. 2018; 12 (1),1600169 

Liu H, Wang L, Zhang S, Leng J, Li N, Li W, Wang J, Tian H, Qi L, Yang X, Yu Z, Tuomilehto J, Hu G. One-year weight losses in the Tianjin Gestational Diabetes Mellitus Prevention Program: A Randomized Clinical Trial. Early View: Diabetes Obes Metab. 2018;20(5):1246-1255.

Khadir A, Kavalakatt S, Cherian P, Warsame S, Abubaker J, Dehbi M, Tiss A. Physical Exercise Enhanced Heat Shock Protein 60 Expression and Attenuated Inflammation in the Adipose Tissue of Human Diabetic Obese. Front Endocrinol. 2018; 9(16)

Brainin M, Feigin V, Martins S, Matz K, Roy J, Sandercock P, Teuschl Y, Tuomilehto J, Wiseman A.  Cut stroke in half: Polypill for primary prevention in stroke. Int J Stroke. 2018;1:1747493018761190.

Acosta T, Barengo N, Arrieta A, Ricaurte C, Tuomilehto J. A demonstration area for type 2 diabetes prevention in Barranquilla and Juan Mina (Colombia) Baseline characteristics of the study participants. Medicine. 2018; 97:1(e9285)